• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于免疫和缺氧相关基因表达的宫颈癌预后模型的鉴定。

Identification of a prognostic model based on immune and hypoxia-related gene expressions in cervical cancer.

机构信息

Department of Gynecology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.

出版信息

J Obstet Gynaecol. 2023 Dec;43(2):2277242. doi: 10.1080/01443615.2023.2277242. Epub 2023 Nov 8.

DOI:10.1080/01443615.2023.2277242
PMID:37938121
Abstract

BACKGROUND

Tumour immune microenvironment (TIME) has long been a key direction of tumour research. Understanding the occurrence, metastasis and other processes of cervical cancer (CC) is of great significance in the diagnosis and prognosis of tumours.

METHODS

Here, this study applied the univariate Cox regression model to determine the prognostic association of immune and hypoxia signature genes in CC, and used Least Absolute Shrinkage and Selection Operator (LASSO) Cox method to build immune and hypoxia related risk score model to uncover the immune signature of the TIME of CC. Moreover, we used experiment to validate the expression level of signature genes. Notably, we assessed the predictive effect of anti-PD1/PDL1 immunotherapy using risk score model.

RESULTS

Through the LASSO Cox regression model, we obtained 12 characteristic genes associated with the prognosis of CC, and also associated with immunity and hypoxia. Interestingly, the high-risk group had the properties of high hypoxia and low immunity, while the low-risk group had the properties of low hypoxia and high immunity. In the low-risk group, patients lived longer and had a significant therapeutic advantage of anti-PD-1 immunotherapy.

CONCLUSIONS

Established risk scores model can help predict response to anti-PD-1 immunotherapy of CC.

摘要

背景

肿瘤免疫微环境(TIME)一直是肿瘤研究的一个关键方向。了解宫颈癌(CC)的发生、转移等过程,对于肿瘤的诊断和预后具有重要意义。

方法

本研究应用单因素 Cox 回归模型来确定免疫和缺氧特征基因与 CC 的预后相关性,并使用最小绝对值收缩和选择算子(LASSO)Cox 方法构建免疫和缺氧相关风险评分模型,以揭示 CC 的 TIME 的免疫特征。此外,我们使用实验验证了特征基因的表达水平。值得注意的是,我们使用风险评分模型评估了抗 PD-1/PD-L1 免疫治疗的预测效果。

结果

通过 LASSO Cox 回归模型,我们获得了 12 个与 CC 预后相关且与免疫和缺氧相关的特征基因。有趣的是,高危组具有高缺氧和低免疫的特性,而低危组具有低缺氧和高免疫的特性。在低危组中,患者的生存期更长,并且对 PD-1 免疫治疗具有显著的治疗优势。

结论

建立的风险评分模型有助于预测 CC 对抗 PD-1 免疫治疗的反应。

相似文献

1
Identification of a prognostic model based on immune and hypoxia-related gene expressions in cervical cancer.基于免疫和缺氧相关基因表达的宫颈癌预后模型的鉴定。
J Obstet Gynaecol. 2023 Dec;43(2):2277242. doi: 10.1080/01443615.2023.2277242. Epub 2023 Nov 8.
2
Construction of a hypoxia-immune-related prognostic model and targeted therapeutic strategies for cervical cancer.构建宫颈癌缺氧免疫相关预后模型及靶向治疗策略。
Int Immunol. 2022 Jul 4;34(7):379-394. doi: 10.1093/intimm/dxac017.
3
Construction of a ferroptosis and hypoxia-related gene signature in cervical cancer to assess tumour immune microenvironment and predict prognosis.构建宫颈癌铁死亡和缺氧相关基因特征,评估肿瘤免疫微环境并预测预后。
J Obstet Gynaecol. 2024 Dec;44(1):2321323. doi: 10.1080/01443615.2024.2321323. Epub 2024 Feb 29.
4
Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.开发一种新型的缺氧免疫相关 LncRNA 风险签名,用于预测结直肠癌的预后和免疫治疗反应。
Front Immunol. 2022 Sep 14;13:951455. doi: 10.3389/fimmu.2022.951455. eCollection 2022.
5
Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.鉴定与宫颈癌肿瘤免疫微环境相关的坏死性凋亡相关预后基因特征,并进行实验验证。
World J Surg Oncol. 2022 Oct 17;20(1):342. doi: 10.1186/s12957-022-02802-z.
6
N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer.N6-甲基腺苷相关长链非编码 RNA 作为预测宫颈癌患者预后和免疫反应的潜在生物标志物。
BMC Genom Data. 2022 Jan 18;23(1):8. doi: 10.1186/s12863-022-01024-2.
7
The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.m6A RNA 甲基化修饰在宫颈癌预后和肿瘤微环境免疫浸润中的意义。
Medicine (Baltimore). 2022 Jul 1;101(26):e29818. doi: 10.1097/MD.0000000000029818.
8
Identification of an inflammatory response-related gene prognostic signature and immune microenvironment for cervical cancer.宫颈癌炎症反应相关基因预后特征及免疫微环境的鉴定
Front Mol Biosci. 2024 Jun 6;11:1394902. doi: 10.3389/fmolb.2024.1394902. eCollection 2024.
9
Identification of cuproptosis-related lncRNA for predicting prognosis and immunotherapeutic response in cervical cancer.鉴定铜死亡相关 lncRNA 预测宫颈癌的预后和免疫治疗反应。
Sci Rep. 2023 Jul 3;13(1):10697. doi: 10.1038/s41598-023-37898-0.
10
A comprehensive study of oxidative stress-related effects on the prognosis and drug therapy of cervical cancer.全面研究氧化应激相关因素对宫颈癌预后和药物治疗的影响。
J Gene Med. 2024 Jan;26(1):e3581. doi: 10.1002/jgm.3581. Epub 2023 Aug 22.